Dietary cod protein improves insulin sensitivity in insulin-resistant men and women: A randomized controlled trial

Diabetes Care

Volumn 30, Issue 11, 2007, Pages 2816-2821

  Ouellet, Véronique ^a,b   Marois, Julie ^a,b   Weisnagel, S John ^b,c   Jacques, Hélène ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CALCIUM; COD PROTEIN; FISH PROTEIN; GLUCOSE; INSULIN; MONOUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; UNCLASSIFIED DRUG; VITAMIN D;

ADULT; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY FIBER; EGG; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MEAT; METABOLIC DISORDER; MILK; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PROTEIN INTAKE;

ANIMALS; BLOOD GLUCOSE; DIETARY FIBER; DIETARY PROTEINS; ENERGY INTAKE; FEMALE; GADUS MORHUA; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE;

EID: 36049006161     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0273     Document Type: Article

References (37)

1. DeFronzo RA: Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88:787-835, 2004
2. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188-1193, 1994
3. Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR: Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet 368:1096-1105, 2006
4. Cavaghan MK, Ehrmann DA, Byrne MM, Polonsky KS: Treatment with oral antidiabetic agent troglitazone improves β cell responses to glucose in subjects with impaired glucose tolerance. J Clin Invest 100: 530-537, 1997
5. von Post-Skagegard M, Vessby B, Karlstrom B: Glucose and insulin responses in healthy women after intake of composite meals containing cod-, milk- and soy protein. Eur J Clin Nutr 60:949-954, 2006
6. Lavigne C, Marette A, Jacques H: Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 278:E491-E500, 2000
7. Lavigne C, Tremblay F, Asselin G, Jacques H, Marette A: Prevention of skeletal muscle insulin resistance by dietary cod protein in high fat-fed rats. Am J Physiol 281:E62-E71, 2001
8. Tremblay F, Lavigne C, Jacques H, Marette A: Dietary cod protein restores insulin-induced activation of phosphatidylinositol 3-kinase/Akt and GLUT4 translocation to the T-tubules in skeletal muscle of high-fat-fed obese rats. Diabetes 52:29-37, 2003
9. Lacaille B, Julien P, Deshaies Y, Lavigne C, Brun LD, Jacques H: Responses of plasma lipoproteins and sex hormones to the consumption of lean fish incorporated in a prudent-type diet in normolipidemic men. J Am Coll Nutr 19:745-753, 2000
10. Beauchesne-Rondeau E, Gascon A, Bergeron J, Jacques H: Plasma lipids and lipoproteins in hypercholesterolemic men fed a lipid-lowering diet containing lean beef, lean fish, or poultry. Am J Clin Nutr 77:587-593, 2003
11. Despres JP, Marette A: Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipidol 5:274-289, 1994
12. Kahn S, McCulloch D, Porte D: Insulin secretion in the normal and diabetic human. In International Textbook of Diabetes Mellitus, 2nd ed. Alberti KGMM, Zimmet P, DeFronzo RA, Keen H, Eds. New York, John Wiley and Sons, 1997, p. 337-354
13. Scarsella C, Alméras N, Mauriège P, Blanchet C, Dewailly E, Després JP, Bergeron J: Determination of reference values for fasting insulin levels in a representative sample of the adult Quebec population. Atherosclerosis 151:101, 2000
14. Escalante Pulido JM, Alpizar Salazar M: Changes in insulin sensitivity, secretion and glucose effectiveness during menstrual cycle. Arch Med Res 30:19-22, 1999
15. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143-3421, 2002
16. American Diabetes Association: Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications (Position Statement). Diabetes Care 25:S50-S60, 2002
17. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids. Washington, DC, National Academy Press, 2002
18. Bureau of Nutritional Sciences Food Directorate, Health Protection Branch: The Canadian Nutrient File. Ottawa, ON, Canada, Department of National Health and Welfare, 1997
19. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, and Institute of Medicine: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC, National Academy Press, 1997
20. Piche ME, Weisnagel SJ, Corneau L, Nadeau A, Bergeron J, Lemieux S: Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women. Diabetes 54:770-777, 2005
21. Bergstrom RW, Wahl PW, Leonetti DL, Fujimoto WY: Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance. J Clin Endocrinol Metab 71:1447-1453, 1990
22. Buchanan TA, Xiang AH, Peters RK, Kjos SL, Berkowitz K, Marroquin A, Goico J, Ochoa C, Azen SP: Response of pancreatic β-cells to improved insulin sensitivity in women at high risk for type 2 diabetes. Diabetes 49:782-788, 2000
23. Hills M, Armitage P: The two-period cross-over clinical trial. Br J Clin Pharmacol 8:7-20, 1979
24. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26 (Suppl. 1):S5-S20, 2003
25. McLaughlin T, Abbasi F, Kim HS, Lamendola C, Schaaf P, Reaven G: Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism 50:795-800, 2001
26. Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL: Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48:839-847, 1999
27. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ: Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73:460-468, 1994
28. Schwenk WF, Haymond MW: Decreased uptake of glucose by human forearm during infusion of leucine, isoleucine, or threonine. Diabetes 36:199-204, 1987
29. Tremblay F, Krebs M, Dombrowski L, Brehm A, Bernroider E, Roth E, Nowotny P, Waldhausl W, Marette A, Roden M: Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 54:2674-2684, 2005
30. Piatti PM, Monti LD, Valsecchi G, Magni F, Setola E, Marchesi F, Galli-Kienle M, Pozza G, Alberti KG: Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients. Diabetes Care 24:875-880, 2001
31. Laidlaw SA, Grosvenor M, Kopple JD: The taurine content of common foodstuffs. JPEN J Parenter Enteral Nutr 14:183-188, 1990
32. Nandhini AT, Thirunavukkarasu V, Anuradha CV: Taurine modifies insulin signaling enzymes in the fructose-fed insulin resistant rats. Diabetes Metab 31:337-344, 2005
33. Nakaya Y, Minami A, Harada N, Sakamoto S, Niwa Y, Ohnaka M: Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr 71:54-58, 2000
34. Visioli F, Rise P, Barassi MC, Marangoni F, Galli C: Dietary intake of fish vs. formulations leads to higher plasma concentrations of n-3 fatty acids. Lipids 38:415-418, 2003
35. Storlien LH, Baur LA, Kriketos AD, Pan DA, Cooney GJ, Jenkins AB, Calvert GD, Campbell LV: Dietary fats and insulin action. Diabetologia 39:621-631, 1996
36. Riccardi G, Giacco R, Rivellese A: Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 23:447-456, 2004
37. Nettleton JA, Katz R: N-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc 105:428-440, 2005